Véronique Dartois
Rutgers University
219 Papers
1.4K Citations
Véronique Dartois is an academic researcher from Rutgers University. The author has contributed to research in topics: Medicine & Mycobacterium tuberculosis. The author has an hindex of 55, co-authored 180 publications. Previous affiliations of Véronique Dartois include Novartis & Scripps Research Institute.
Chat about Author
Papers
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis.
Bibhuti B. Mishra,Rustin R. Lovewell,Andrew J. Olive,Guoliang Zhang,Wenfei Wang,Eliseo A. Eugenin,Clare M. Smith,Jia Yao Phuah,Jarukit E. Long,Michelle L. Dubuke,Samantha G. Palace,Jon D. Goguen,Richard Baker,Subhalaxmi Nambi,Rabinarayan Mishra,Matthew G. Booty,Christina E. Baer,Scott A. Shaffer,Véronique Dartois,Beth A. McCormick,Xinchun Chen,Christopher M. Sassetti +21 more
TL;DR: The data suggest that M. tuberculosis exploits neutrophilic inflammation to preferentially replicate at sites of tissue damage that promote contagion, and that a similar inflammatory pathway promotes tuberculosis in patients.
High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.
Brendan Prideaux,Véronique Dartois,Dieter Staab,Danielle M. Weiner,Anne Goh,Laura E. Via,Clifton E. Barry,Markus Stoeckli +7 more
TL;DR: The MALDI-MRM-MSI method was shown to be a rapid and sensitive method for analyzing the distribution of anti-TB compounds and will be applied to distribution studies of additional drugs in the future.
253
NTM drug discovery: status, gaps and the way forward
TL;DR: The current status of NTM drug development is summarized, knowledge gaps and scientific obstacles are highlighted, and strategies to reduce biological uncertainties and to begin to populate a N TM drug pipeline with attractive leads and drug candidates are proposed.
233
Fatty acid synthesis is required for breast cancer brain metastasis.
Gino B. Ferraro,Ahmed Ali,Alba Luengo,David P. Kodack,David P. Kodack,Amy Deik,Keene L. Abbott,Divya Bezwada,Landry Blanc,Landry Blanc,Brendan Prideaux,Brendan Prideaux,Xin Jin,Jessica M. Possada,Jiang Chen,Christopher R. Chin,Zohreh Amoozgar,Raphael Ferreira,Raphael Ferreira,Ivy X. Chen,Kamila Naxerova,Christopher W. Ng,Anna M. Westermark,Mark Duquette,Sylvie Roberge,Neal I. Lindeman,Costas A. Lyssiotis,Costas A. Lyssiotis,Jens Nielsen,David E. Housman,Dan G. Duda,Elena F. Brachtel,Todd R. Golub,Lewis C. Cantley,Lewis C. Cantley,John M. Asara,Shawn M. Davidson,Shawn M. Davidson,Dai Fukumura,Véronique Dartois,Clary B. Clish,Rakesh K. Jain,Matthew G. Vander Heiden,Matthew G. Vander Heiden +43 more
- 01 Apr 2021
TL;DR: It is determined that genetic or pharmacological inhibition of fatty acid synthase (FASN) reduces HER2+ breast tumor growth in the brain, demonstrating that differences in nutrient availability across metastatic sites can result in targetable metabolic dependencies.
226
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
Scott G. Franzblau,Mary Ann DeGroote,Sang-Hyun Cho,Koen Andries,Eric L. Nuermberger,Ian M. Orme,Khisimuzi Mdluli,Iñigo Angulo-Barturen,Thomas Dick,Véronique Dartois,Anne J. Lenaerts +10 more
TL;DR: The goals of this document are to recommend protocols and hence accelerate the process of TB drug discovery and testing, with remaining questions and critical gaps that are in need of further validation and experimentation.
221